<p>阿卡迪亚医疗保健公司（NASDAQ:ACHC - 获取免费报告）周四股价下跌 20.5%。该股最低交易价为 24.25 美元，最后交易价为 22.4550 美元。交易期间大约成交 711,208 股，较平均每日成交量 3,474,513 股下降了 80%。该股此前收盘价为 28.26 美元。</p>
<p>获取 <strong>Acadia Healthcare</strong> 警报：</p>
<h2>更多阿卡迪亚医疗保健新闻</h2>
<ul>
<li>Neurogene 股票暴跌 44%：这家生物科技公司还有希望吗？</li>
</ul>
<p>以下是本周影响阿卡迪亚医疗保健的主要新闻：</p>
<ul>
<li>积极情绪：第一季度业绩超出预期——每股收益 0.37 美元，预期 0.28 美元，收入 8.288 亿美元（同比增长 7.6%）。强劲的同设施收入驱动因素（每患者日收入增加和适度的患者日增长）显示出潜在需求。阿卡迪亚医疗保健（ACHC）第一季度收益和收入超出预期。</li>
<li>积极情绪：异常大的看涨期权活动——交易者购买了约 3,427 份看涨期权（约比平均水平高出 112%），表明投机性看涨头寸，可能在任何确认消息中放大上涨空间。</li>
<li>积极情绪：来自知名价值投资经理的投资者兴趣被强调（阿卡迪亚出现在一些低调推荐名单上），这可能支持长期需求。大卫·艾因霍恩的 5 个低调推荐。</li>
<li>中性情绪：公司发布了完整的新闻稿、幻灯片和召开了电话会议——对建模患者组合、定价趋势和并购评论有用，但在没有进一步细节的情况下不具方向性。阿卡迪亚医疗保健宣布 2026 年第一季度业绩。</li>
<li>消极情绪：第二季度指导低于预期——每股收益指导为 0.30–0.40 美元，而市场预期约为 0.46 美元，收入指导为 8.35 亿–8.50 亿美元，而市场预期约为 8.67 亿美元。该指导缺口是近期主要的负面催化剂，给股价施加压力。</li>
<li>消极情绪：临时首席财务官的任命引发了领导力/稳定性问题，并可能导致投资者对执行和财务节奏的不确定性。临时首席财务官的任命考验阿卡迪亚医疗保健的领导稳定性和 2026 年目标。</li>
<li>消极情绪：市场反应：尽管季度业绩超出预期，但头条新闻指出由于指导/领导问题股价下跌——这反映了市场关注前瞻性指导和执行风险。阿卡迪亚医疗保健 NASDAQ: ACHC 在 2026 年第一季度销售超出预期，但股价下跌。</li>
</ul>
<h2>华尔街分析师观点</h2>
<p>多家研究分析师最近对该公司发布了报告。Weiss Ratings 在 1 月 21 日的报告中重申了对阿卡迪亚医疗保健股票的 “卖出（d）” 评级。Guggenheim 将阿卡迪亚医疗保健的目标价从 27.00 美元下调至 22.00 美元，并在 2 月 23 日的报告中对该股给予 “买入” 评级。Jefferies Financial Group 在 4 月 20 日的报告中重申了 “持有” 评级，并将阿卡迪亚医疗保健的目标价设定为 24.50 美元。瑞银集团在 4 月 17 日的报告中将阿卡迪亚医疗保健的目标价从 27.00 美元上调至 31.00 美元，并给予该股 “买入” 评级。最后，Raymond James Financial 在 2 月 26 日的报告中重申了 “跑赢大盘” 评级，并将阿卡迪亚医疗保健的目标价设定为 25.00 美元。七位投资分析师对该股给予 “买入” 评级，七位给予 “持有” 评级，两位对该公司的股票给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股目前的平均评级为 “持有”，共识目标价为 23.04 美元。</p>
<p><strong>查看我们最新的阿卡迪亚医疗保健股票报告</strong></p>
<h2>阿卡迪亚医疗保健价格表现</h2>
<p>该股市值为 21.3 亿美元，市盈率为-1.88，市盈率增长比率为 9.51，贝塔值为 0.71。公司当前比率为 1.55，速动比率为 1.55，债务与股本比率为 1.27。该股的 50 日简单移动平均线为 24.25 美元，200 日简单移动平均线为 19.15 美元。</p>
<p>阿卡迪亚医疗保健（NASDAQ:ACHC - 获取免费报告）最后一次公布季度收益数据是在 4 月 29 日，报告每股收益为 0.37 美元，超出分析师共识预期的 0.28 美元，超出 0.09 美元。阿卡迪亚医疗保健的股本回报率为 6.53%，净利润率为-33.29%。该公司在该季度的收入为 8.288 亿美元，而分析师预期为 8.2289 亿美元。去年同期，该公司每股收益为 0.40 美元。该公司的季度收入同比增长 7.6%。阿卡迪亚医疗保健已将其 2026 年第二季度的指导设定为每股收益 0.300-0.400 美元。根据分析师的平均预测，阿卡迪亚医疗保健公司预计本财年将发布 1.48 美元的每股收益。</p>
<h2>机构资金流入和流出</h2>
<p>多家机构投资者最近对其在 ACHC 的持仓进行了调整。Principal Financial Group Inc. 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 112.1%。Principal Financial Group Inc. 目前拥有 442,943 股该公司的股票，价值 10,967,000 美元，此前在上个季度购买了 234,107 股。Invenomic Capital Management LP 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 41.6%。Invenomic Capital Management LP 目前拥有 1,936,396 股该公司的股票，价值 47,945,000 美元，此前在上个季度购买了 568,796 股。Vanguard Group Inc. 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 7.8%。Vanguard Group Inc. 目前拥有 9,417,045 股该公司的股票，价值 233,166,000 美元，此前在上个季度购买了 681,278 股。First Citizens Bank &amp; Trust Co. 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 164.1%。First Citizens Bank &amp; Trust Co. 目前拥有 59,123 股该公司的股票，价值 1,464,000 美元，此前在上个季度购买了 36,733 股。最后，公共部门养老金投资委员会在第三季度收购了阿卡迪亚医疗保健的新股份，价值约为 8,919,000 美元。</p>
<h2>关于阿卡迪亚医疗保健</h2>
<p>(获取免费报告)</p>
<p>阿卡迪亚医疗保健公司（Acadia Healthcare Company, Inc）NASDAQ: ACHC 是一家公开交易的行为健康服务提供商，总部位于田纳西州富兰克林。公司成立于 2005 年，通过有机扩展和战略收购不断发展，已成为美国心理健康和成瘾治疗领域的领先专业机构。</p>
<p>阿卡迪亚运营着一个多元化的网络，包括住院精神病医院、住院治疗中心、门诊诊所和强化门诊项目。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票超过阿卡迪亚医疗保健</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1000 美元在阿卡迪亚医疗保健吗？</h2>
<p>在考虑阿卡迪亚医疗保健之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而阿卡迪亚医疗保健并不在名单上。</p>
<p>虽然阿卡迪亚医疗保健目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

阿卡迪亚医疗保健

<p>阿卡迪亚医疗保健 (NASDAQ:ACHC) 的股价下跌了 20.5%，至 22.4550 美元，此前该公司提供的第二季度指引低于市场预期，预计每股收益为 0.30–0.40 美元，而市场预期为 0.46 美元。尽管第一季度表现强劲，但临时首席财务官的任命引发了对领导稳定性的担忧。分析师的评级各异，平均评级为 “持有”，共识目标价为 23.04 美元。该公司的市值为 21.3 亿美元，净利润率为负 33.29%</p>

<p>Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Get Free Report) dropped 20.5% on Thursday . The stock traded as low as $24.25 and last traded at $22.4550. Approximately 711,208 shares were traded during trading, a decline of 80% from the average daily volume of 3,474,513 shares. The stock had previously closed at $28.26.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健公司（NASDAQ:ACHC - 获取免费报告）周四股价下跌 20.5%。该股最低交易价为 24.25 美元，最后交易价为 22.4550 美元。交易期间大约成交 711,208 股，较平均每日成交量 3,474,513 股下降了 80%。该股此前收盘价为 28.26 美元。</p>
</div><p>Get <strong>Acadia Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Acadia Healthcare</strong> 警报：</p>
</div><h2>More Acadia Healthcare News</h2>
<div class="lb-trans"><h2>更多阿卡迪亚医疗保健新闻</h2>
</div><ul>
<li>Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?&#34;</li>
</ul>
<div class="lb-trans"><ul>
<li>Neurogene 股票暴跌 44%：这家生物科技公司还有希望吗？</li>
</ul>
</div><p>Here are the key news stories impacting Acadia Healthcare this week:</p>
<div class="lb-trans"><p>以下是本周影响阿卡迪亚医疗保健的主要新闻：</p>
</div><ul>
<li>Positive Sentiment: Q1 results beat expectations — EPS $0.37 vs. consensus $0.28 and revenue $828.8M (+7.6% YoY). Strong same-facility revenue drivers (higher revenue per patient day and modest patient-day growth) show underlying demand. Acadia Healthcare (ACHC) Q1 Earnings and Revenues Beat Estimates</li>
<li>Positive Sentiment: Unusually large call-option activity — traders bought ~3,427 calls (about 112% above average), indicating speculative bullish positioning that can amplify upside on any confirming news.</li>
<li>Positive Sentiment: Investor interest from notable value managers is being highlighted (Acadia appears on lists of under-the-radar picks), which can support longer-term demand. 5 Under-the-Radar Picks from David Einhorn</li>
<li>Neutral Sentiment: Company released full press release, slide deck and hosted a conference call — useful for modeling patient-mix, pricing trends and M&amp;A commentary but not immediately directional without further detail. Acadia Healthcare Announces First Quarter 2026 Results</li>
<li>Negative Sentiment: Q2 guidance came in below consensus — EPS guide $0.30–$0.40 vs. Street ~$0.46 and revenue guide $835–$850M vs. ~$867M consensus. This guidance shortfall is the primary near-term negative catalyst pressuring the stock.</li>
<li>Negative Sentiment: Interim CFO appointment raises leadership/stability questions and could create investor uncertainty around execution and financial cadence. Interim CFO Appointment Tests Acadia Healthcare Leadership Stability And 2026 Targets</li>
<li>Negative Sentiment: Market reaction: despite the quarterly beat, headlines note the stock dropped on the guidance/leadership concerns — this reflects the market focusing on forward guidance and execution risk. Acadia Healthcare NASDAQ: ACHC Surprises With Q1 CY2026 Sales But Stock Drops</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：第一季度业绩超出预期——每股收益 0.37 美元，预期 0.28 美元，收入 8.288 亿美元（同比增长 7.6%）。强劲的同设施收入驱动因素（每患者日收入增加和适度的患者日增长）显示出潜在需求。阿卡迪亚医疗保健（ACHC）第一季度收益和收入超出预期。</li>
<li>积极情绪：异常大的看涨期权活动——交易者购买了约 3,427 份看涨期权（约比平均水平高出 112%），表明投机性看涨头寸，可能在任何确认消息中放大上涨空间。</li>
<li>积极情绪：来自知名价值投资经理的投资者兴趣被强调（阿卡迪亚出现在一些低调推荐名单上），这可能支持长期需求。大卫·艾因霍恩的 5 个低调推荐。</li>
<li>中性情绪：公司发布了完整的新闻稿、幻灯片和召开了电话会议——对建模患者组合、定价趋势和并购评论有用，但在没有进一步细节的情况下不具方向性。阿卡迪亚医疗保健宣布 2026 年第一季度业绩。</li>
<li>消极情绪：第二季度指导低于预期——每股收益指导为 0.30–0.40 美元，而市场预期约为 0.46 美元，收入指导为 8.35 亿–8.50 亿美元，而市场预期约为 8.67 亿美元。该指导缺口是近期主要的负面催化剂，给股价施加压力。</li>
<li>消极情绪：临时首席财务官的任命引发了领导力/稳定性问题，并可能导致投资者对执行和财务节奏的不确定性。临时首席财务官的任命考验阿卡迪亚医疗保健的领导稳定性和 2026 年目标。</li>
<li>消极情绪：市场反应：尽管季度业绩超出预期，但头条新闻指出由于指导/领导问题股价下跌——这反映了市场关注前瞻性指导和执行风险。阿卡迪亚医疗保健 NASDAQ: ACHC 在 2026 年第一季度销售超出预期，但股价下跌。</li>
</ul>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>A number of research analysts recently issued reports on the company. Weiss Ratings reaffirmed a &#34;sell (d)&#34; rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Guggenheim lowered their target price on Acadia Healthcare from $27.00 to $22.00 and set a &#34;buy&#34; rating on the stock in a report on Monday, February 23rd. Jefferies Financial Group reaffirmed a &#34;hold&#34; rating and set a $24.50 target price on shares of Acadia Healthcare in a report on Monday, April 20th. UBS Group lifted their target price on Acadia Healthcare from $27.00 to $31.00 and gave the stock a &#34;buy&#34; rating in a report on Friday, April 17th. Finally, Raymond James Financial reaffirmed an &#34;outperform&#34; rating and set a $25.00 target price on shares of Acadia Healthcare in a report on Thursday, February 26th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Hold&#34; and a consensus price target of $23.04.</p>
<div class="lb-trans"><p>多家研究分析师最近对该公司发布了报告。Weiss Ratings 在 1 月 21 日的报告中重申了对阿卡迪亚医疗保健股票的 “卖出（d）” 评级。Guggenheim 将阿卡迪亚医疗保健的目标价从 27.00 美元下调至 22.00 美元，并在 2 月 23 日的报告中对该股给予 “买入” 评级。Jefferies Financial Group 在 4 月 20 日的报告中重申了 “持有” 评级，并将阿卡迪亚医疗保健的目标价设定为 24.50 美元。瑞银集团在 4 月 17 日的报告中将阿卡迪亚医疗保健的目标价从 27.00 美元上调至 31.00 美元，并给予该股 “买入” 评级。最后，Raymond James Financial 在 2 月 26 日的报告中重申了 “跑赢大盘” 评级，并将阿卡迪亚医疗保健的目标价设定为 25.00 美元。七位投资分析师对该股给予 “买入” 评级，七位给予 “持有” 评级，两位对该公司的股票给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股目前的平均评级为 “持有”，共识目标价为 23.04 美元。</p>
</div><p><strong>View Our Latest Stock Report on Acadia Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的阿卡迪亚医疗保健股票报告</strong></p>
</div><h2>Acadia Healthcare Price Performance</h2>
<div class="lb-trans"><h2>阿卡迪亚医疗保健价格表现</h2>
</div><p>The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of -1.88, a price-to-earnings-growth ratio of 9.51 and a beta of 0.71. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. The stock has a 50-day simple moving average of $24.25 and a 200 day simple moving average of $19.15.</p>
<div class="lb-trans"><p>该股市值为 21.3 亿美元，市盈率为-1.88，市盈率增长比率为 9.51，贝塔值为 0.71。公司当前比率为 1.55，速动比率为 1.55，债务与股本比率为 1.27。该股的 50 日简单移动平均线为 24.25 美元，200 日简单移动平均线为 19.15 美元。</p>
</div><p>Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm had revenue of $828.80 million during the quarter, compared to analyst estimates of $822.89 million. During the same period last year, the company posted $0.40 EPS. The business's quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities research analysts forecast that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健（NASDAQ:ACHC - 获取免费报告）最后一次公布季度收益数据是在 4 月 29 日，报告每股收益为 0.37 美元，超出分析师共识预期的 0.28 美元，超出 0.09 美元。阿卡迪亚医疗保健的股本回报率为 6.53%，净利润率为-33.29%。该公司在该季度的收入为 8.288 亿美元，而分析师预期为 8.2289 亿美元。去年同期，该公司每股收益为 0.40 美元。该公司的季度收入同比增长 7.6%。阿卡迪亚医疗保健已将其 2026 年第二季度的指导设定为每股收益 0.300-0.400 美元。根据分析师的平均预测，阿卡迪亚医疗保健公司预计本财年将发布 1.48 美元的每股收益。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors have recently made changes to their positions in ACHC. Principal Financial Group Inc. grew its holdings in Acadia Healthcare by 112.1% in the 3rd quarter. Principal Financial Group Inc. now owns 442,943 shares of the company's stock valued at $10,967,000 after buying an additional 234,107 shares during the last quarter. Invenomic Capital Management LP grew its holdings in Acadia Healthcare by 41.6% in the 3rd quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company's stock valued at $47,945,000 after buying an additional 568,796 shares during the last quarter. Vanguard Group Inc. grew its holdings in Acadia Healthcare by 7.8% in the 3rd quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company's stock valued at $233,166,000 after buying an additional 681,278 shares during the last quarter. First Citizens Bank &amp; Trust Co. grew its holdings in Acadia Healthcare by 164.1% in the 3rd quarter. First Citizens Bank &amp; Trust Co. now owns 59,123 shares of the company's stock valued at $1,464,000 after buying an additional 36,733 shares during the last quarter. Finally, Public Sector Pension Investment Board acquired a new stake in Acadia Healthcare in the 3rd quarter valued at approximately $8,919,000.</p>
<div class="lb-trans"><p>多家机构投资者最近对其在 ACHC 的持仓进行了调整。Principal Financial Group Inc. 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 112.1%。Principal Financial Group Inc. 目前拥有 442,943 股该公司的股票，价值 10,967,000 美元，此前在上个季度购买了 234,107 股。Invenomic Capital Management LP 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 41.6%。Invenomic Capital Management LP 目前拥有 1,936,396 股该公司的股票，价值 47,945,000 美元，此前在上个季度购买了 568,796 股。Vanguard Group Inc. 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 7.8%。Vanguard Group Inc. 目前拥有 9,417,045 股该公司的股票，价值 233,166,000 美元，此前在上个季度购买了 681,278 股。First Citizens Bank &amp; Trust Co. 在第三季度将其在阿卡迪亚医疗保健的持仓增加了 164.1%。First Citizens Bank &amp; Trust Co. 目前拥有 59,123 股该公司的股票，价值 1,464,000 美元，此前在上个季度购买了 36,733 股。最后，公共部门养老金投资委员会在第三季度收购了阿卡迪亚医疗保健的新股份，价值约为 8,919,000 美元。</p>
</div><h2>About Acadia Healthcare</h2>
<div class="lb-trans"><h2>关于阿卡迪亚医疗保健</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.</p>
<div class="lb-trans"><p>阿卡迪亚医疗保健公司（Acadia Healthcare Company, Inc）NASDAQ: ACHC 是一家公开交易的行为健康服务提供商，总部位于田纳西州富兰克林。公司成立于 2005 年，通过有机扩展和战略收购不断发展，已成为美国心理健康和成瘾治疗领域的领先专业机构。</p>
</div><p>Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.</p>
<div class="lb-trans"><p>阿卡迪亚运营着一个多元化的网络，包括住院精神病医院、住院治疗中心、门诊诊所和强化门诊项目。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Acadia Healthcare</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过阿卡迪亚医疗保健</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Acadia Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在阿卡迪亚医疗保健吗？</h2>
</div><p>Before you consider Acadia Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑阿卡迪亚医疗保健之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Acadia Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而阿卡迪亚医疗保健并不在名单上。</p>
</div><p>While Acadia Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然阿卡迪亚医疗保健目前在分析师中被评为持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Acadia Healthcare (NASDAQ:ACHC)  Shares Down 20.5%   - Here's What Happened

Market Beat

Neurogene

阿卡迪亚医疗保健（NASDAQ:ACHC）股价下跌 20.5% - 事件详情如下